Primary Care

In a retrospective national VA cohort of nearly 1 million Veterans, tobacco smoking duration criteria identified more screening-eligible patients and fewer missed lung cancer diagnoses than pack-year...

In a retrospective national VA cohort of nearly 1 million Veterans, tobacco smoking duration criteria identified more screening-eligible patients and fewer missed lung cancer diagnoses than pack-year...

In a retrospective national VA cohort of nearly 1 million Veterans, tobacco smoking duration criteria identified more screening-eligible patients and fewer missed lung cancer diagnoses than pack-year...

In a retrospective national VA cohort of nearly 1 million Veterans, tobacco smoking duration criteria identified more screening-eligible patients and fewer missed lung cancer diagnoses than pack-year...

In a retrospective national VA cohort of nearly 1 million Veterans, tobacco smoking duration criteria identified more screening-eligible patients and fewer missed lung cancer diagnoses than pack-year...

In a retrospective national VA cohort of nearly 1 million Veterans, tobacco smoking duration criteria identified more screening-eligible patients and fewer missed lung cancer diagnoses than pack-year...

In interim INFUSE data, ≥50% of adults with prior anti-CGRP preventive failure reported cognitive symptom improvement after eptinezumab.

In interim INFUSE data, ≥50% of adults with prior anti-CGRP preventive failure reported cognitive symptom improvement after eptinezumab.

In interim INFUSE data, ≥50% of adults with prior anti-CGRP preventive failure reported cognitive symptom improvement after eptinezumab.

In interim INFUSE data, ≥50% of adults with prior anti-CGRP preventive failure reported cognitive symptom improvement after eptinezumab.